Charles River: Vanguard reports 7.38% stake
Charles River Laboratories International Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 3,634,376 shares of Common Stock, representing 7.38% of the class as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Charles River Laboratories International Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 3,634,376 shares of Common Stock, representing 7.38% of the class as of 03/31/2026. The filing shows sole voting power for 432,172 shares and sole dispositive power for 3,634,376 shares. The filing is signed on 04/29/2026 by Ashley Grim, Head of Global Fund Administration.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
sole dispositive power regulatory
sole voting power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Vanguard Capital Management report in CRL?
When was the CRL Schedule 13G signed and who signed it?
What date does the reported ownership for CRL reference?
Does the filing indicate other parties have more than 5% of CRL?
AI-generated analysis. How Rhea-AI works. Not financial advice.